Effect of prostaglandin analogues on anterior scleral thickness and corneal thickness in patients with primary open-angle glaucoma

Prostaglandin (PG) analogues are usually prescribed as a first-line therapy in patients with glaucoma because of its once-daily dosing benefit and effective intraocular pressure (IOP) reduction. However, the mechanism of PG analogues is not completely understood. In this study, we investigated the e...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports Vol. 11; no. 1; pp. 11098 - 8
Main Authors: Park, Ji-Hye, Yoo, Chungkwon, Chung, Hyun Woo, Kim, Yong Yeon
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 27.05.2021
Nature Portfolio
Subjects:
692/699/3161/3169/3170
692/699/3161/3172
Humanities and Social Sciences
multidisciplinary
Science
Science (multidisciplinary)
ISSN:2045-2322, 2045-2322
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Prostaglandin (PG) analogues are usually prescribed as a first-line therapy in patients with glaucoma because of its once-daily dosing benefit and effective intraocular pressure (IOP) reduction. However, the mechanism of PG analogues is not completely understood. In this study, we investigated the effect of PG analogues on the anterior scleral thickness (AST) in treatment-naïve eyes with primary open-angle glaucoma using anterior segment optical coherence tomography. The AST was measured at the location of the scleral spur, 1000 μm, and 2000 μm posterior to the scleral spur and was compared before and after using the medications for 3 months and 1 year. Among 54 patients enrolled in this study, 31 patients used prostaglandin analogues and 23 patients used dorzolamide/timolol fixed combination (DTFC) drugs. There was no significant difference in untreated IOP, glaucoma severity, and baseline AST values between the two groups. While there was no significant changes in AST after using the DTFC drugs, the AST at all 3 locations showed a significant reduction in both the nasal and temporal sectors after using PG analogues for 1 year (all, P  < 0.05). These findings suggest that the AST reduction after using PG analogues might be related with the increased uveoscleral outflow.
AbstractList Abstract Prostaglandin (PG) analogues are usually prescribed as a first-line therapy in patients with glaucoma because of its once-daily dosing benefit and effective intraocular pressure (IOP) reduction. However, the mechanism of PG analogues is not completely understood. In this study, we investigated the effect of PG analogues on the anterior scleral thickness (AST) in treatment-naïve eyes with primary open-angle glaucoma using anterior segment optical coherence tomography. The AST was measured at the location of the scleral spur, 1000 μm, and 2000 μm posterior to the scleral spur and was compared before and after using the medications for 3 months and 1 year. Among 54 patients enrolled in this study, 31 patients used prostaglandin analogues and 23 patients used dorzolamide/timolol fixed combination (DTFC) drugs. There was no significant difference in untreated IOP, glaucoma severity, and baseline AST values between the two groups. While there was no significant changes in AST after using the DTFC drugs, the AST at all 3 locations showed a significant reduction in both the nasal and temporal sectors after using PG analogues for 1 year (all, P < 0.05). These findings suggest that the AST reduction after using PG analogues might be related with the increased uveoscleral outflow.
Prostaglandin (PG) analogues are usually prescribed as a first-line therapy in patients with glaucoma because of its once-daily dosing benefit and effective intraocular pressure (IOP) reduction. However, the mechanism of PG analogues is not completely understood. In this study, we investigated the effect of PG analogues on the anterior scleral thickness (AST) in treatment-naïve eyes with primary open-angle glaucoma using anterior segment optical coherence tomography. The AST was measured at the location of the scleral spur, 1000 μm, and 2000 μm posterior to the scleral spur and was compared before and after using the medications for 3 months and 1 year. Among 54 patients enrolled in this study, 31 patients used prostaglandin analogues and 23 patients used dorzolamide/timolol fixed combination (DTFC) drugs. There was no significant difference in untreated IOP, glaucoma severity, and baseline AST values between the two groups. While there was no significant changes in AST after using the DTFC drugs, the AST at all 3 locations showed a significant reduction in both the nasal and temporal sectors after using PG analogues for 1 year (all, P < 0.05). These findings suggest that the AST reduction after using PG analogues might be related with the increased uveoscleral outflow.
Prostaglandin (PG) analogues are usually prescribed as a first-line therapy in patients with glaucoma because of its once-daily dosing benefit and effective intraocular pressure (IOP) reduction. However, the mechanism of PG analogues is not completely understood. In this study, we investigated the effect of PG analogues on the anterior scleral thickness (AST) in treatment-naïve eyes with primary open-angle glaucoma using anterior segment optical coherence tomography. The AST was measured at the location of the scleral spur, 1000 μm, and 2000 μm posterior to the scleral spur and was compared before and after using the medications for 3 months and 1 year. Among 54 patients enrolled in this study, 31 patients used prostaglandin analogues and 23 patients used dorzolamide/timolol fixed combination (DTFC) drugs. There was no significant difference in untreated IOP, glaucoma severity, and baseline AST values between the two groups. While there was no significant changes in AST after using the DTFC drugs, the AST at all 3 locations showed a significant reduction in both the nasal and temporal sectors after using PG analogues for 1 year (all, P  < 0.05). These findings suggest that the AST reduction after using PG analogues might be related with the increased uveoscleral outflow.
Prostaglandin (PG) analogues are usually prescribed as a first-line therapy in patients with glaucoma because of its once-daily dosing benefit and effective intraocular pressure (IOP) reduction. However, the mechanism of PG analogues is not completely understood. In this study, we investigated the effect of PG analogues on the anterior scleral thickness (AST) in treatment-naïve eyes with primary open-angle glaucoma using anterior segment optical coherence tomography. The AST was measured at the location of the scleral spur, 1000 μm, and 2000 μm posterior to the scleral spur and was compared before and after using the medications for 3 months and 1 year. Among 54 patients enrolled in this study, 31 patients used prostaglandin analogues and 23 patients used dorzolamide/timolol fixed combination (DTFC) drugs. There was no significant difference in untreated IOP, glaucoma severity, and baseline AST values between the two groups. While there was no significant changes in AST after using the DTFC drugs, the AST at all 3 locations showed a significant reduction in both the nasal and temporal sectors after using PG analogues for 1 year (all, P < 0.05). These findings suggest that the AST reduction after using PG analogues might be related with the increased uveoscleral outflow.Prostaglandin (PG) analogues are usually prescribed as a first-line therapy in patients with glaucoma because of its once-daily dosing benefit and effective intraocular pressure (IOP) reduction. However, the mechanism of PG analogues is not completely understood. In this study, we investigated the effect of PG analogues on the anterior scleral thickness (AST) in treatment-naïve eyes with primary open-angle glaucoma using anterior segment optical coherence tomography. The AST was measured at the location of the scleral spur, 1000 μm, and 2000 μm posterior to the scleral spur and was compared before and after using the medications for 3 months and 1 year. Among 54 patients enrolled in this study, 31 patients used prostaglandin analogues and 23 patients used dorzolamide/timolol fixed combination (DTFC) drugs. There was no significant difference in untreated IOP, glaucoma severity, and baseline AST values between the two groups. While there was no significant changes in AST after using the DTFC drugs, the AST at all 3 locations showed a significant reduction in both the nasal and temporal sectors after using PG analogues for 1 year (all, P < 0.05). These findings suggest that the AST reduction after using PG analogues might be related with the increased uveoscleral outflow.
ArticleNumber 11098
Author Yoo, Chungkwon
Kim, Yong Yeon
Chung, Hyun Woo
Park, Ji-Hye
Author_xml – sequence: 1
  givenname: Ji-Hye
  surname: Park
  fullname: Park, Ji-Hye
  organization: Department of Ophthalmology, Korea University College of Medicine
– sequence: 2
  givenname: Chungkwon
  surname: Yoo
  fullname: Yoo, Chungkwon
  email: ckyoomd@korea.ac.kr
  organization: Department of Ophthalmology, Korea University College of Medicine
– sequence: 3
  givenname: Hyun Woo
  surname: Chung
  fullname: Chung, Hyun Woo
  organization: Department of Ophthalmology, Korea University College of Medicine
– sequence: 4
  givenname: Yong Yeon
  surname: Kim
  fullname: Kim, Yong Yeon
  organization: Department of Ophthalmology, Korea University College of Medicine
BookMark eNp9Us9vFCEUJqbG1tp_wNMcvUwFhhngYmKaaps08aJn8paBWdZZWIHV9Opf7tvOxrgeygV4733f-_W9JmcxRUfIW0avGe3U-yJYr1VLOWs1HfTQihfkglPRt7zj_Oyf9zm5KmVD8fRcC6ZfkfNOoHOg9IL8vvXe2dok3-xyKhWmGeIYYgMR5jTtXWnS4VNdDik3xc4uw9zUdbDfoysFXWNjU47uxIoEO6jBxVqaX6GukTxsIT82aediC3GaXYOZ9jZt4Q156WEu7up4X5Jvn26_3ty1D18-3998fGitULq2XmhPewkgOg6K2V4yxQZrNY5Bd86DpFZwrjgT0HE6soGNWvp-0E54UKvuktwvvGOCjTkWZBIE82RIeTKQa8AOzQDd2HuuBEgQo7IgR8lW4CSTVjEJyPVh4drtV1s3WmwUx3JCeuqJYW2m9NNgyZRThQTvjgQ5_cApV7MNxboZp-_Svhjed2JgHHvFUL6EWlxQyc7_TcOoOWjBLFowqAXzpAUjEKT-A9lQcSPpUE6Yn4d2C7Rgnji5bDZpn1EO5TnUH0R1zG0
CitedBy_id crossref_primary_10_3390_diagnostics14060655
crossref_primary_10_3390_jcm13154564
crossref_primary_10_3390_pharmaceutics16020274
crossref_primary_10_1016_j_genrep_2022_101653
crossref_primary_10_1038_s41598_023_46709_5
crossref_primary_10_1111_aos_15725
crossref_primary_10_3389_fmed_2022_923308
crossref_primary_10_3389_fmed_2024_1356839
crossref_primary_10_3389_fphar_2022_1015338
crossref_primary_10_1007_s00417_024_06378_0
crossref_primary_10_1038_s41598_022_27346_w
crossref_primary_10_1097_IJG_0000000000002438
crossref_primary_10_1016_j_matdes_2025_114767
crossref_primary_10_1007_s00417_021_05523_3
crossref_primary_10_1038_s41598_021_97746_x
crossref_primary_10_3390_biomedicines12092000
crossref_primary_10_1167_tvst_14_8_28
Cites_doi 10.1016/j.ophtha.2015.10.053
10.1001/archopht.119.8.1165
10.1136/bjophthalmol-2016-309295
10.3928/1542-8877-20000301-19
10.1016/j.exer.2009.02.007
10.1016/S0002-9394(98)00436-X
10.1016/j.survophthal.2008.08.010
10.1371/journal.pone.0132902
10.1016/j.ophtha.2007.07.002
10.1097/IJG.0b013e3181dde051
10.1136/bjophthalmol-2016-308505
10.1097/IJG.0b013e31816b2fd1
10.1007/s00417-015-3072-5
10.1001/archophthalmol.2007.46
10.1097/01.ijg.0000212220.42675.c5
10.1016/j.ajo.2013.11.008
10.1006/exer.1998.0508
10.1111/j.1755-3768.1985.tb01540.x
10.1167/iovs.03-0990
10.1111/j.1755-3768.1985.tb06813.x
10.1038/sj.tpj.6500181
10.1001/archopht.117.6.794
10.1167/iovs.09-4559
10.1016/0014-4835(77)90123-3
10.1167/iovs.06-0334
10.1016/S0140-6736(14)62111-5
10.1016/j.exer.2018.07.023
10.1007/s00417-013-2285-8
10.1097/ICO.0000000000000422
ContentType Journal Article
Copyright The Author(s) 2021
Copyright_xml – notice: The Author(s) 2021
DBID C6C
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1038/s41598-021-90696-4
DatabaseName Springer Nature OA Free Journals
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList

CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 8
ExternalDocumentID oai_doaj_org_article_6a3d5f284a7a4d8ca7d71bae717c817a
PMC8160208
10_1038_s41598_021_90696_4
GrantInformation_xml – fundername: Korea University Grant
  grantid: K1925021
– fundername: ;
  grantid: K1925021
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFFHD
AFPKN
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c489t-f49f057aa432a81c571816cc959893efa70c4228214a320d161d97f569e4fa8b3
IEDL.DBID DOA
ISICitedReferencesCount 20
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000658389400013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2045-2322
IngestDate Tue Oct 14 19:06:26 EDT 2025
Tue Nov 04 01:57:47 EST 2025
Fri Sep 05 06:12:27 EDT 2025
Sat Nov 29 05:58:13 EST 2025
Tue Nov 18 21:31:48 EST 2025
Fri Feb 21 02:39:42 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c489t-f49f057aa432a81c571816cc959893efa70c4228214a320d161d97f569e4fa8b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://doaj.org/article/6a3d5f284a7a4d8ca7d71bae717c817a
PMID 34045600
PQID 2534612432
PQPubID 23479
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_6a3d5f284a7a4d8ca7d71bae717c817a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8160208
proquest_miscellaneous_2534612432
crossref_primary_10_1038_s41598_021_90696_4
crossref_citationtrail_10_1038_s41598_021_90696_4
springer_journals_10_1038_s41598_021_90696_4
PublicationCentury 2000
PublicationDate 2021-05-27
PublicationDateYYYYMMDD 2021-05-27
PublicationDate_xml – month: 05
  year: 2021
  text: 2021-05-27
  day: 27
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationYear 2021
Publisher Nature Publishing Group UK
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Portfolio
References PrumBEJrPrimary open-angle glaucoma preferred practice pattern(®) guidelinesOphthalmology2016123P41P11110.1016/j.ophtha.2015.10.053
ParkHLLeeNYChoiJAParkCKMeasurement of scleral thickness using swept-source optical coherence tomography in patients with open-angle glaucoma and myopiaAm. J. Ophthalmol.201415787588410.1016/j.ajo.2013.11.008
KagemannLIdentification and assessment of Schlemm's canal by spectral-domain optical coherence tomographyInvest. Ophthalmol. Vis Sci.2010514054405910.1167/iovs.09-4559
EbneterAHänerNUZinkernagelMSMetrics of the normal anterior sclera imaging with optical coherence tomographyGraefes Arch. Clin. Exp. Ophthalmol.20152531575158010.1007/s00417-015-3072-5
OcklindAEffect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sectionsExp. Eye Res.1998671791911:CAS:528:DyaK1cXmt1KntLc%3D10.1006/exer.1998.0508
PekelGComparison of corneal layers and anterior sclera in emmetropic and myopic eyesCornea20153478679010.1097/ICO.0000000000000422
KimCYTreatment patterns and medication adherence of patients with glaucoma in South KoreaBr. J. Ophthalmol.201710180180710.1136/bjophthalmol-2016-308505
Allingham, R.R., Damji, K.F., Freedman, S., Moroi, S.E. & Rhee, D.J. Cellular and molecular biology of aqueous humor dynamics in Shields' Textbook of Glaucoma (6th ed.), 3–23 (Lippincott Williams & Wilkins, 2012).
CrowstonJGAiharaMLindseyJDWeinrebRNEffect of latanoprost on outflow facility in the mouseInvest. Ophthalmol. Vis. Sci.2004452240224510.1167/iovs.03-0990
TorisCBAqueous humor dynamics in the aging human eyeAm. J. Ophthalmol.19991274074121:STN:280:DyaK1M3jtlSlsw%3D%3D10.1016/S0002-9394(98)00436-X
LimKSMechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover studyOphthalmology200811579079510.1016/j.ophtha.2007.07.002
KimJWIncreased human scleral permeability with prostaglandin exposureInvest. Ophthalmol. Vis Sci.200142151415211:STN:280:DC%2BD3M3pvVOrug%3D%3D11381055
EsakiKIshikawaHLiebmannJMRitchRA technique for performing ultrasound biomicroscopy in the sitting and prone positionsOphthalmic. Surg. Lasers2000311661691:STN:280:DC%2BD3c3gsFyjsg%3D%3D10.3928/1542-8877-20000301-19
Woodman-PieterseECReadSACollinsMJAlonso-CaneiroDAnterior scleral thickness changes with accommodation in myopes and emmetropesExp. Eye Res.2018177961031:CAS:528:DC%2BC1cXhsVKrtLrP10.1016/j.exer.2018.07.023
Garway-HeathDFLatanoprost for open-angle glaucoma (UKGTS): A randomised, multicentre, placebo-controlled trialLancet2015385129513041:CAS:528:DC%2BC2MXmtVSisA%3D%3D10.1016/S0140-6736(14)62111-5
WeinrebRNEnhancement of scleral macromolecular permeability with prostaglandinsTrans. Am. Ophthalmol. Soc.2001993193431:STN:280:DC%2BD38%2FntFyguw%3D%3D117973171359020
YooCEomYSSuhYWKimYYCentral corneal thickness and anterior scleral thickness in Korean patients with open-angle glaucoma: an anterior segment optical coherence studyJ. Glaucoma.201120959910.1097/IJG.0b013e3181dde051
McLarenNCMoroiSEClinical implications of pharmacogenetics for glaucoma therapeuticsPharmacogen. J.200331972011:CAS:528:DC%2BD3sXmsFWisrk%3D10.1038/sj.tpj.6500181
TunTAAssessment of trabecular meshwork width using swept source optical coherence tomographyGraefes Arch. Clin. Exp. Ophthalmol.20132511587159210.1007/s00417-013-2285-8
WeinrebRNProstaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cellsInvest. Ophthalmol. Vis. Sci.199738277227801:STN:280:DyaK1c%2FnvF2msQ%3D%3D9418730
SagaraTTopical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathwayArch. Ophthalmol.19991177948011:CAS:528:DyaK1MXktVaksr0%3D10.1001/archopht.117.6.794
OliveiraCTelloCLiebmannJRitchRCentral corneal thickness is not related to anterior scleral thickness or axial lengthJ. Glaucoma.20061519019410.1097/01.ijg.0000212220.42675.c5
Mohamed-NoorJCorrelation between corneal and scleral thickness in glaucomaJ. Glaucoma.200918323610.1097/IJG.0b013e31816b2fd1
ThiemeHMechanisms of action of unoprostone on trabecular meshwork contractilityInvest. Ophthalmol. Vis. Sci.200142319332011:STN:280:DC%2BD3MjgtVCjsQ%3D%3D11726622
InomataHBillAExit sites of uveoscleral flow of aqueous humor in cynomolgus monkey eyesExp. Eye Res.1977251131181:STN:280:DyaE1c%2FisVWhtQ%3D%3D10.1016/0014-4835(77)90123-3
GatonDDIncreased matrix metalloproteinases 1, 2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F (2 alpha)-isopropyl ester treatmentArch. Ophthalmol.2001119116511701:CAS:528:DC%2BD3MXmsV2ntLw%3D10.1001/archopht.119.8.1165
BuckhurstHDGilmartinBCubbidgeRPLoganNSMeasurement of scleral thickness in humans using anterior segment optical coherent tomographyPLoS ONE201510e013290210.1371/journal.pone.0132902
TammERThe trabecular meshwork outflow pathways: Structural and functional aspectsExp. Eye Res.2009886486551:CAS:528:DC%2BD1MXkslyhtL8%3D10.1016/j.exer.2009.02.007
LindseyJDCrowstonJGTranAMorrisCWeinrebRNDirect matrix metalloproteinase enhancement of transscleral permeabilityInvest. Ophthalmol. Vis. Sci.20074875275510.1167/iovs.06-0334
SakataLMAssessment of the scleral spur in anterior segment optical coherence tomography imagesArch. Ophthalmol.200812618118510.1001/archophthalmol.2007.46
LiPCharacteristics and variations of in vivo Schlemm's canal and collector channel microstructures in enhanced-depth imaging optical coherence tomographyBr. J. Ophthalmol.201710180881310.1136/bjophthalmol-2016-309295
NornMPigment spots related to scleral emissaries in Eskimos, Mongols, and CaucasiansActa Ophthalmol. (Copenh).1985632362411:STN:280:DyaL2M3itFCrsw%3D%3D10.1111/j.1755-3768.1985.tb01540.x
NornMTopography of scleral emissaries and sclera-perforating blood vesselsActa Ophthalmol. (Copenh).1985633203221:STN:280:DyaL2MzgtlWgsw%3D%3D10.1111/j.1755-3768.1985.tb06813.x
TorisCBGabeltBTKaufmanPLUpdate on the mechanism of action of topical prostaglandins for intraocular pressure reductionSurv. Ophthalmol.200853Suppl 1S10712010.1016/j.survophthal.2008.08.010
CB Toris (90696_CR3) 1999; 127
T Sagara (90696_CR15) 1999; 117
RN Weinreb (90696_CR13) 1997; 38
G Pekel (90696_CR23) 2015; 34
M Norn (90696_CR26) 1985; 63
JG Crowston (90696_CR9) 2004; 45
JW Kim (90696_CR16) 2001; 42
TA Tun (90696_CR21) 2013; 251
H Thieme (90696_CR11) 2001; 42
90696_CR1
C Oliveira (90696_CR28) 2006; 15
ER Tamm (90696_CR2) 2009; 88
BE Prum Jr (90696_CR7) 2016; 123
C Yoo (90696_CR29) 2011; 20
HD Buckhurst (90696_CR30) 2015; 10
J Mohamed-Noor (90696_CR31) 2009; 18
A Ocklind (90696_CR14) 1998; 67
RN Weinreb (90696_CR17) 2001; 99
LM Sakata (90696_CR34) 2008; 126
DD Gaton (90696_CR12) 2001; 119
A Ebneter (90696_CR22) 2015; 253
CY Kim (90696_CR5) 2017; 101
EC Woodman-Pieterse (90696_CR24) 2018; 177
M Norn (90696_CR27) 1985; 63
L Kagemann (90696_CR19) 2010; 51
H Inomata (90696_CR25) 1977; 25
K Esaki (90696_CR33) 2000; 31
NC McLaren (90696_CR4) 2003; 3
JD Lindsey (90696_CR18) 2007; 48
CB Toris (90696_CR8) 2008; 53
HL Park (90696_CR32) 2014; 157
KS Lim (90696_CR10) 2008; 115
P Li (90696_CR20) 2017; 101
DF Garway-Heath (90696_CR6) 2015; 385
References_xml – reference: OcklindAEffect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sectionsExp. Eye Res.1998671791911:CAS:528:DyaK1cXmt1KntLc%3D10.1006/exer.1998.0508
– reference: TunTAAssessment of trabecular meshwork width using swept source optical coherence tomographyGraefes Arch. Clin. Exp. Ophthalmol.20132511587159210.1007/s00417-013-2285-8
– reference: GatonDDIncreased matrix metalloproteinases 1, 2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F (2 alpha)-isopropyl ester treatmentArch. Ophthalmol.2001119116511701:CAS:528:DC%2BD3MXmsV2ntLw%3D10.1001/archopht.119.8.1165
– reference: TorisCBGabeltBTKaufmanPLUpdate on the mechanism of action of topical prostaglandins for intraocular pressure reductionSurv. Ophthalmol.200853Suppl 1S10712010.1016/j.survophthal.2008.08.010
– reference: SakataLMAssessment of the scleral spur in anterior segment optical coherence tomography imagesArch. Ophthalmol.200812618118510.1001/archophthalmol.2007.46
– reference: NornMPigment spots related to scleral emissaries in Eskimos, Mongols, and CaucasiansActa Ophthalmol. (Copenh).1985632362411:STN:280:DyaL2M3itFCrsw%3D%3D10.1111/j.1755-3768.1985.tb01540.x
– reference: TammERThe trabecular meshwork outflow pathways: Structural and functional aspectsExp. Eye Res.2009886486551:CAS:528:DC%2BD1MXkslyhtL8%3D10.1016/j.exer.2009.02.007
– reference: LimKSMechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover studyOphthalmology200811579079510.1016/j.ophtha.2007.07.002
– reference: NornMTopography of scleral emissaries and sclera-perforating blood vesselsActa Ophthalmol. (Copenh).1985633203221:STN:280:DyaL2MzgtlWgsw%3D%3D10.1111/j.1755-3768.1985.tb06813.x
– reference: YooCEomYSSuhYWKimYYCentral corneal thickness and anterior scleral thickness in Korean patients with open-angle glaucoma: an anterior segment optical coherence studyJ. Glaucoma.201120959910.1097/IJG.0b013e3181dde051
– reference: ParkHLLeeNYChoiJAParkCKMeasurement of scleral thickness using swept-source optical coherence tomography in patients with open-angle glaucoma and myopiaAm. J. Ophthalmol.201415787588410.1016/j.ajo.2013.11.008
– reference: WeinrebRNProstaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cellsInvest. Ophthalmol. Vis. Sci.199738277227801:STN:280:DyaK1c%2FnvF2msQ%3D%3D9418730
– reference: EbneterAHänerNUZinkernagelMSMetrics of the normal anterior sclera imaging with optical coherence tomographyGraefes Arch. Clin. Exp. Ophthalmol.20152531575158010.1007/s00417-015-3072-5
– reference: KagemannLIdentification and assessment of Schlemm's canal by spectral-domain optical coherence tomographyInvest. Ophthalmol. Vis Sci.2010514054405910.1167/iovs.09-4559
– reference: EsakiKIshikawaHLiebmannJMRitchRA technique for performing ultrasound biomicroscopy in the sitting and prone positionsOphthalmic. Surg. Lasers2000311661691:STN:280:DC%2BD3c3gsFyjsg%3D%3D10.3928/1542-8877-20000301-19
– reference: ThiemeHMechanisms of action of unoprostone on trabecular meshwork contractilityInvest. Ophthalmol. Vis. Sci.200142319332011:STN:280:DC%2BD3MjgtVCjsQ%3D%3D11726622
– reference: PrumBEJrPrimary open-angle glaucoma preferred practice pattern(®) guidelinesOphthalmology2016123P41P11110.1016/j.ophtha.2015.10.053
– reference: BuckhurstHDGilmartinBCubbidgeRPLoganNSMeasurement of scleral thickness in humans using anterior segment optical coherent tomographyPLoS ONE201510e013290210.1371/journal.pone.0132902
– reference: LiPCharacteristics and variations of in vivo Schlemm's canal and collector channel microstructures in enhanced-depth imaging optical coherence tomographyBr. J. Ophthalmol.201710180881310.1136/bjophthalmol-2016-309295
– reference: LindseyJDCrowstonJGTranAMorrisCWeinrebRNDirect matrix metalloproteinase enhancement of transscleral permeabilityInvest. Ophthalmol. Vis. Sci.20074875275510.1167/iovs.06-0334
– reference: OliveiraCTelloCLiebmannJRitchRCentral corneal thickness is not related to anterior scleral thickness or axial lengthJ. Glaucoma.20061519019410.1097/01.ijg.0000212220.42675.c5
– reference: Garway-HeathDFLatanoprost for open-angle glaucoma (UKGTS): A randomised, multicentre, placebo-controlled trialLancet2015385129513041:CAS:528:DC%2BC2MXmtVSisA%3D%3D10.1016/S0140-6736(14)62111-5
– reference: CrowstonJGAiharaMLindseyJDWeinrebRNEffect of latanoprost on outflow facility in the mouseInvest. Ophthalmol. Vis. Sci.2004452240224510.1167/iovs.03-0990
– reference: KimCYTreatment patterns and medication adherence of patients with glaucoma in South KoreaBr. J. Ophthalmol.201710180180710.1136/bjophthalmol-2016-308505
– reference: KimJWIncreased human scleral permeability with prostaglandin exposureInvest. Ophthalmol. Vis Sci.200142151415211:STN:280:DC%2BD3M3pvVOrug%3D%3D11381055
– reference: PekelGComparison of corneal layers and anterior sclera in emmetropic and myopic eyesCornea20153478679010.1097/ICO.0000000000000422
– reference: TorisCBAqueous humor dynamics in the aging human eyeAm. J. Ophthalmol.19991274074121:STN:280:DyaK1M3jtlSlsw%3D%3D10.1016/S0002-9394(98)00436-X
– reference: WeinrebRNEnhancement of scleral macromolecular permeability with prostaglandinsTrans. Am. Ophthalmol. Soc.2001993193431:STN:280:DC%2BD38%2FntFyguw%3D%3D117973171359020
– reference: Woodman-PieterseECReadSACollinsMJAlonso-CaneiroDAnterior scleral thickness changes with accommodation in myopes and emmetropesExp. Eye Res.2018177961031:CAS:528:DC%2BC1cXhsVKrtLrP10.1016/j.exer.2018.07.023
– reference: Mohamed-NoorJCorrelation between corneal and scleral thickness in glaucomaJ. Glaucoma.200918323610.1097/IJG.0b013e31816b2fd1
– reference: Allingham, R.R., Damji, K.F., Freedman, S., Moroi, S.E. & Rhee, D.J. Cellular and molecular biology of aqueous humor dynamics in Shields' Textbook of Glaucoma (6th ed.), 3–23 (Lippincott Williams & Wilkins, 2012).
– reference: SagaraTTopical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathwayArch. Ophthalmol.19991177948011:CAS:528:DyaK1MXktVaksr0%3D10.1001/archopht.117.6.794
– reference: McLarenNCMoroiSEClinical implications of pharmacogenetics for glaucoma therapeuticsPharmacogen. J.200331972011:CAS:528:DC%2BD3sXmsFWisrk%3D10.1038/sj.tpj.6500181
– reference: InomataHBillAExit sites of uveoscleral flow of aqueous humor in cynomolgus monkey eyesExp. Eye Res.1977251131181:STN:280:DyaE1c%2FisVWhtQ%3D%3D10.1016/0014-4835(77)90123-3
– volume: 123
  start-page: P41
  year: 2016
  ident: 90696_CR7
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2015.10.053
– volume: 119
  start-page: 1165
  year: 2001
  ident: 90696_CR12
  publication-title: Arch. Ophthalmol.
  doi: 10.1001/archopht.119.8.1165
– volume: 101
  start-page: 808
  year: 2017
  ident: 90696_CR20
  publication-title: Br. J. Ophthalmol.
  doi: 10.1136/bjophthalmol-2016-309295
– volume: 31
  start-page: 166
  year: 2000
  ident: 90696_CR33
  publication-title: Ophthalmic. Surg. Lasers
  doi: 10.3928/1542-8877-20000301-19
– volume: 88
  start-page: 648
  year: 2009
  ident: 90696_CR2
  publication-title: Exp. Eye Res.
  doi: 10.1016/j.exer.2009.02.007
– volume: 127
  start-page: 407
  year: 1999
  ident: 90696_CR3
  publication-title: Am. J. Ophthalmol.
  doi: 10.1016/S0002-9394(98)00436-X
– volume: 42
  start-page: 3193
  year: 2001
  ident: 90696_CR11
  publication-title: Invest. Ophthalmol. Vis. Sci.
– volume: 53
  start-page: S107
  issue: Suppl 1
  year: 2008
  ident: 90696_CR8
  publication-title: Surv. Ophthalmol.
  doi: 10.1016/j.survophthal.2008.08.010
– volume: 10
  start-page: e0132902
  year: 2015
  ident: 90696_CR30
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0132902
– volume: 115
  start-page: 790
  year: 2008
  ident: 90696_CR10
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2007.07.002
– volume: 20
  start-page: 95
  year: 2011
  ident: 90696_CR29
  publication-title: J. Glaucoma.
  doi: 10.1097/IJG.0b013e3181dde051
– volume: 101
  start-page: 801
  year: 2017
  ident: 90696_CR5
  publication-title: Br. J. Ophthalmol.
  doi: 10.1136/bjophthalmol-2016-308505
– volume: 18
  start-page: 32
  year: 2009
  ident: 90696_CR31
  publication-title: J. Glaucoma.
  doi: 10.1097/IJG.0b013e31816b2fd1
– volume: 253
  start-page: 1575
  year: 2015
  ident: 90696_CR22
  publication-title: Graefes Arch. Clin. Exp. Ophthalmol.
  doi: 10.1007/s00417-015-3072-5
– volume: 38
  start-page: 2772
  year: 1997
  ident: 90696_CR13
  publication-title: Invest. Ophthalmol. Vis. Sci.
– ident: 90696_CR1
– volume: 126
  start-page: 181
  year: 2008
  ident: 90696_CR34
  publication-title: Arch. Ophthalmol.
  doi: 10.1001/archophthalmol.2007.46
– volume: 99
  start-page: 319
  year: 2001
  ident: 90696_CR17
  publication-title: Trans. Am. Ophthalmol. Soc.
– volume: 15
  start-page: 190
  year: 2006
  ident: 90696_CR28
  publication-title: J. Glaucoma.
  doi: 10.1097/01.ijg.0000212220.42675.c5
– volume: 42
  start-page: 1514
  year: 2001
  ident: 90696_CR16
  publication-title: Invest. Ophthalmol. Vis Sci.
– volume: 157
  start-page: 875
  year: 2014
  ident: 90696_CR32
  publication-title: Am. J. Ophthalmol.
  doi: 10.1016/j.ajo.2013.11.008
– volume: 67
  start-page: 179
  year: 1998
  ident: 90696_CR14
  publication-title: Exp. Eye Res.
  doi: 10.1006/exer.1998.0508
– volume: 63
  start-page: 236
  year: 1985
  ident: 90696_CR27
  publication-title: Acta Ophthalmol. (Copenh).
  doi: 10.1111/j.1755-3768.1985.tb01540.x
– volume: 45
  start-page: 2240
  year: 2004
  ident: 90696_CR9
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.03-0990
– volume: 63
  start-page: 320
  year: 1985
  ident: 90696_CR26
  publication-title: Acta Ophthalmol. (Copenh).
  doi: 10.1111/j.1755-3768.1985.tb06813.x
– volume: 3
  start-page: 197
  year: 2003
  ident: 90696_CR4
  publication-title: Pharmacogen. J.
  doi: 10.1038/sj.tpj.6500181
– volume: 117
  start-page: 794
  year: 1999
  ident: 90696_CR15
  publication-title: Arch. Ophthalmol.
  doi: 10.1001/archopht.117.6.794
– volume: 51
  start-page: 4054
  year: 2010
  ident: 90696_CR19
  publication-title: Invest. Ophthalmol. Vis Sci.
  doi: 10.1167/iovs.09-4559
– volume: 25
  start-page: 113
  year: 1977
  ident: 90696_CR25
  publication-title: Exp. Eye Res.
  doi: 10.1016/0014-4835(77)90123-3
– volume: 48
  start-page: 752
  year: 2007
  ident: 90696_CR18
  publication-title: Invest. Ophthalmol. Vis. Sci.
  doi: 10.1167/iovs.06-0334
– volume: 385
  start-page: 1295
  year: 2015
  ident: 90696_CR6
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)62111-5
– volume: 177
  start-page: 96
  year: 2018
  ident: 90696_CR24
  publication-title: Exp. Eye Res.
  doi: 10.1016/j.exer.2018.07.023
– volume: 251
  start-page: 1587
  year: 2013
  ident: 90696_CR21
  publication-title: Graefes Arch. Clin. Exp. Ophthalmol.
  doi: 10.1007/s00417-013-2285-8
– volume: 34
  start-page: 786
  year: 2015
  ident: 90696_CR23
  publication-title: Cornea
  doi: 10.1097/ICO.0000000000000422
SSID ssj0000529419
Score 2.4306672
Snippet Prostaglandin (PG) analogues are usually prescribed as a first-line therapy in patients with glaucoma because of its once-daily dosing benefit and effective...
Abstract Prostaglandin (PG) analogues are usually prescribed as a first-line therapy in patients with glaucoma because of its once-daily dosing benefit and...
SourceID doaj
pubmedcentral
proquest
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 11098
SubjectTerms 692/699/3161/3169/3170
692/699/3161/3172
Humanities and Social Sciences
multidisciplinary
Science
Science (multidisciplinary)
Title Effect of prostaglandin analogues on anterior scleral thickness and corneal thickness in patients with primary open-angle glaucoma
URI https://link.springer.com/article/10.1038/s41598-021-90696-4
https://www.proquest.com/docview/2534612432
https://pubmed.ncbi.nlm.nih.gov/PMC8160208
https://doaj.org/article/6a3d5f284a7a4d8ca7d71bae717c817a
Volume 11
WOSCitedRecordID wos000658389400013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: DOA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M~E
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Biological Science Database (ProQuest)
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M7P
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: 7X7
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: BENPR
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Publicly Available Content Database
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: PIMPY
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database (ProQuest)
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M2P
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagBakXxFOkwMpI3CBq4jixfaSoFUh0FSFAy8madeyyokrQZheJK7-cGSdbNT2UCxdLsR07npl4xvb4G8ZeySYTzpdl6k2uUwmQpSChSF0uliqERvjo7f71o5rP9WJh6iuhvsgnbIAHHgh3VEHRlAEnUVAgG-1ANSpfgsdliNO5iqZRpsyVxdSA6i2MzM14SyYr9FGPmopuk0WPhMpUqZxoogjYP7Eyr_tIXjsojfrn9D67NxqO_O3wwQ_YLd8-ZHeHUJK_H7E_Awwx7wL_SRc5IMbmWLUc2mF7pucdPRA0c7fmPbaB_XHydv9Bsx0WNRxXoq2f5GIDI_Jqz2nLFhuP6BScom6l0J5feI49bVFu4TH7cnry-d37dIyvkDqpzSYN0gQ01wBkIUDnrkQ9lVfOGSSUKXwAlTlCCBM5ck9kDRqHjVGhrIyXAfSyeML22q71TxknlDUFjVQOjGwqsSy1cICKT9LOnQoJy3e0tm4EH6cYGBc2HoIX2g78scgfG_ljZcJeX74zDu7G2sfEwsuaBJsdM1CY7ChM9l_ClLCXOwGw-JvR2Qm0vtv2VpSFRGMQKZUwNZGMSY_Tknb1PQJ2I1UpFmrC3uxkyI4zRX_DiA7_x4iesQNBMp_RzcPnbG-z3voX7I77tVn16xm7rRYqpnrG9o9P5vWnWfyRMD0TNaUK0_36w1n97S-CUSRZ
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+prostaglandin+analogues+on+anterior+scleral+thickness+and+corneal+thickness+in+patients+with+primary+open-angle+glaucoma&rft.jtitle=Scientific+reports&rft.au=Ji-Hye+Park&rft.au=Chungkwon+Yoo&rft.au=Hyun+Woo+Chung&rft.au=Yong+Yeon+Kim&rft.date=2021-05-27&rft.pub=Nature+Portfolio&rft.eissn=2045-2322&rft.volume=11&rft.issue=1&rft.spage=1&rft.epage=8&rft_id=info:doi/10.1038%2Fs41598-021-90696-4&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_6a3d5f284a7a4d8ca7d71bae717c817a
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon